Pulmonary Hypertension Association (PHA) leaders recently participated in several international conferences on pulmonary hypertension (PH). Their participation represents PHA’s longstanding leadership in PH research, policy and patient support.
On Nov. 19, PHA CEO Matt Granato participated in Knowing the Challenges of the Pulmonary Hypertension Community in Latin America, which was virtual for the first time. He served on a panel about the role of patient organizations in social participation in health. The online conference featured experts from the scientific medical community, patient groups and government officials. Other panelists included Gergely Meszaros of PH Europe, Enrique Carazo of the Foundation Against Pulmonary Hypertension of Spain and Paula Cabral of Pulmonary Hypertension Mexico.
Matt also participated virtually in the Nov. 5 Fuwai Forum on Right Heart and Pulmonary Vascular Disease and Guangdong-Hong Kong-Macao International Conference on Pulmonary Vascular Disease. The conference, presented from Shenzhen, China, aimed to provide a platform for scientific exchange of new ideas, clinical experience and findings. The organizers also are trying to start a PHA-like organization in the Hong Kong-Macau area.
Also on Nov. 5, Katie Kroner, PHA’s vice president of advocacy and patient engagement, spoke about PHA at the Duke University Medical Center Patient Day.